Inga Zerr Selected Research

Codon (Codons)

1/2022	Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
1/2021	TREM2 expression in the brain and biological fluids in prion diseases.
1/2021	Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease.
1/2019	Age at onset in genetic prion disease and the design of preventive clinical trials.
1/2017	Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.
1/2017	Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.
11/2016	Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
1/2016	Identification of new molecular alterations in fatal familial insomnia.
5/2015	Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.
2/2015	Characteristic CSF prion seeding efficiency in humans with prion diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inga Zerr Research Topics

Disease

58	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 11/2004
44	Sporadic Creutzfeldt-Jakob Disease 09/2022 - 01/2004
41	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
41	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 06/2002
40	Dementia (Dementias) 05/2022 - 08/2003
36	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 03/2005
17	Parkinson Disease (Parkinson's Disease) 05/2022 - 11/2016
15	Scrapie 04/2020 - 11/2002
13	Acquired CJD 12/2020 - 01/2002
11	Disease Progression 05/2022 - 01/2005
10	Cognitive Dysfunction 05/2022 - 01/2013
10	Synucleinopathies 01/2022 - 01/2016
9	Fatal Familial Insomnia 01/2022 - 10/2009
7	Brain Diseases (Brain Disorder) 01/2022 - 12/2009
7	Infections 01/2021 - 01/2008
7	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2020 - 11/2010
6	Inflammation (Inflammations) 01/2021 - 01/2013
5	Proteostasis Deficiencies 11/2021 - 01/2016
5	Frontotemporal Dementia (Semantic Dementia) 11/2020 - 05/2008
4	Pathologic Processes 09/2018 - 11/2010
4	Gliosis 01/2018 - 09/2006
3	Schizophrenia (Dementia Praecox) 12/2020 - 08/2010
3	Nervous System Diseases (Neurological Disorders) 08/2020 - 05/2008
3	Ataxia (Dyssynergia) 01/2020 - 02/2009
3	Tauopathies 01/2018 - 01/2016
3	Brain Ischemia (Cerebral Ischemia) 01/2008 - 11/2004
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 12/2020
2	Catatonia 01/2021 - 12/2020
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2018
2	Autism Spectrum Disorder 01/2021 - 12/2020
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 12/2020
2	Metabolic Diseases (Metabolic Disease) 12/2020 - 05/2017
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2020 - 09/2013
2	Neuroblastoma 04/2020 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2020 - 09/2013
2	Myoclonus (Nocturnal Myoclonus) 01/2018 - 11/2002
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018 - 01/2017
2	Neoplasms (Cancer) 11/2017 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 10/2015
2	Rare Diseases (Rare Disease) 01/2016 - 02/2014
2	Ischemic Stroke 09/2015 - 11/2013
2	Cerebral Small Vessel Diseases 01/2014 - 01/2013
2	Brain Injuries (Brain Injury) 05/2006 - 11/2004
2	Ischemia 05/2006 - 11/2004
1	Encephalitis (Encephalitis, Rasmussen) 01/2022

Drug/Important Bio-Agent (IBA)

68	Prion ProteinsIBA 01/2022 - 01/2002
55	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2005
33	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
31	PrionsIBA 01/2022 - 11/2006
24	Codon (Codons)IBA 01/2022 - 01/2002
13	SynucleinsIBA 05/2022 - 10/2015
10	tau Proteins (tau Protein)IBA 01/2022 - 01/2005
10	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2008
9	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
9	Methionine (L-Methionine)FDA Link 01/2021 - 11/2002
9	14-3-3 Proteins (14-3-3 Protein)IBA 02/2020 - 09/2005
8	ProteomeIBA 01/2020 - 11/2010
7	Protein Isoforms (Isoforms)IBA 11/2019 - 11/2004
7	CytokinesIBA 09/2015 - 10/2005
6	Valine (L-Valine)FDA Link 01/2021 - 02/2009
6	ApolipoproteinsIBA 01/2020 - 08/2010
5	Peptides (Polypeptides)IBA 08/2020 - 08/2003
5	EnzymesIBA 01/2020 - 11/2010
4	Biological ProductsIBA 01/2022 - 01/2018
4	alpha-SynucleinIBA 01/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 12/2020 - 09/2013
4	Peptide Hydrolases (Proteases)FDA Link 10/2017 - 11/2010
3	AutoantibodiesIBA 01/2021 - 12/2020
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Mitochondrial DNA (mtDNA)IBA 08/2020 - 10/2015
3	Amyloid beta-PeptidesIBA 08/2020 - 08/2003
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2007
3	Protein AggregatesIBA 01/2018 - 08/2013
3	Doxycycline (Periostat)FDA LinkGeneric 02/2017 - 02/2014
3	Interleukin-8 (Interleukin 8)IBA 09/2015 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 04/2010
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2011 - 09/2006
3	Endopeptidase K (Proteinase K)IBA 10/2008 - 01/2002
2	AntibodiesIBA 01/2022 - 01/2020
2	Lipocalin-2IBA 01/2022 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2021
2	LigandsIBA 11/2021 - 11/2020
2	ChemokinesIBA 11/2020 - 01/2013
2	SPADIBA 08/2020 - 01/2020
2	NeurograninIBA 05/2020 - 01/2019
2	SteroidsIBA 01/2020 - 10/2018
2	PresenilinsIBA 01/2020 - 01/2017
2	Reelin ProteinIBA 01/2020 - 10/2017
2	ImmunosorbentsIBA 01/2020 - 11/2019
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 11/2019 - 11/2016
2	Phosphotransferases (Kinase)IBA 05/2018 - 08/2015
2	purineIBA 01/2017 - 01/2016
2	AlbuminsIBA 11/2015 - 01/2013
2	Interleukin-4 (Interleukin 4)IBA 09/2015 - 10/2005
2	LipidsIBA 06/2014 - 07/2002
2	CholesterolIBA 03/2013 - 08/2010
2	ElementsIBA 01/2011 - 04/2010

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2007